Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Natasha K Brockwell"'
Autor:
Damien J Zanker, Alex J Spurling, Natasha K Brockwell, Katie L Owen, Jasmine M Zakhour, Tina Robinson, Hendrika M Duivenvoorden, Paul J Hertzog, Stefanie R Mullins, Robert W Wilkinson, Belinda S Parker
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 9, Pp n/a-n/a (2020)
Abstract Objectives Loss of tumor‐inherent type I interferon (IFN) signalling has been closely linked to accelerated metastatic progression via decreased immunogenicity and antitumor immunity. Previous studies in murine models of triple‐negative
Externí odkaz:
https://doaj.org/article/61578605bee846698ae1d74398aee779
Autor:
Hendrika M. Duivenvoorden, Natasha K. Brockwell, Cameron J. Nowell, Kaylene J. Simpson, Belinda S. Parker
Publikováno v:
Scientific Data, Vol 8, Iss 1, Pp 1-10 (2021)
Measurement(s) cell proliferation assay • Myoepithelial Cell • cell viability assay • protein expression assay Technology Type(s) cell counting technique • high content screen of cells treated with library of siRNAs • imaging technique •
Externí odkaz:
https://doaj.org/article/982ef1919d4f4253a677cdd0dfe07351
Autor:
Belinda S. Parker, Elgene Lim, Phillip K. Darcy, Sherene Loi, Franco Caramia, Nikola Baschuk, Hendrika M. Duivenvoorden, Jai Rautela, Alex Spurling, Damien Zanker, Katie L. Owen, Natasha K. Brockwell
Figure legends for supplementary figures 1, 2 & 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3499bd9355a04dac47fccd01d1025b6
https://doi.org/10.1158/2326-6066.22537178.v1
https://doi.org/10.1158/2326-6066.22537178.v1
Autor:
Belinda S. Parker, Elgene Lim, Phillip K. Darcy, Sherene Loi, Franco Caramia, Nikola Baschuk, Hendrika M. Duivenvoorden, Jai Rautela, Alex Spurling, Damien Zanker, Katie L. Owen, Natasha K. Brockwell
The effect of combination treatment on T cell activation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d4f94fe5a5e07717a1c3e0e4da0cb1a
https://doi.org/10.1158/2326-6066.22537181.v1
https://doi.org/10.1158/2326-6066.22537181.v1
Autor:
Belinda S. Parker, Elgene Lim, Phillip K. Darcy, Sherene Loi, Franco Caramia, Nikola Baschuk, Hendrika M. Duivenvoorden, Jai Rautela, Alex Spurling, Damien Zanker, Katie L. Owen, Natasha K. Brockwell
The lack of targeted therapies available for triple-negative breast cancer (TNBC) patients who fail to respond to first-line chemotherapy has sparked interest in immunotherapeutic approaches. However, trials utilizing checkpoint inhibitors targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12dc36d7bdeb3d3c3e14c923091f5dc9
https://doi.org/10.1158/2326-6066.c.6548339.v1
https://doi.org/10.1158/2326-6066.c.6548339.v1
Autor:
Corinne Ooi, Alex Spurling, Jane Fox, Vinod Ganju, Linden J. Gearing, Michelle White, Beena Kumar, Damien Zanker, Timothy J. Molloy, Hendrika M. Duivenvoorden, Helen E. Cumming, Jasmine M. Zakhour, Kate Harvey, Siddhartha Deb, Tina Robinson, Marion Harris, Paul J. Hertzog, Natasha K Brockwell, Jai Rautela, Sandra O’ Toole, Jacqui Thomson, Chia-Ling Chan, Niantao Deng, Belinda S. Parker, Katie L. Owen, Alexander Swarbrick, Nicole Potasz
Publikováno v:
npj Precision Oncology, Vol 3, Iss 1, Pp 1-13 (2019)
NPJ Precision Oncology
NPJ Precision Oncology
Patients diagnosed with triple negative breast cancer (TNBC) have an increased risk of rapid metastasis compared to other subtypes. Predicting long-term survival post-chemotherapy in patients with TNBC is difficult, yet enhanced infiltration of tumor
Publikováno v:
Cytokine. 118:42-47
Immunotherapy has revolutionized cancer treatment, with sustained responses to immune checkpoint inhibitors reported in a number of malignancies. Such therapeutics are now being trialed in aggressive or advanced cancers that are heavily reliant on un
Autor:
Alex Spurling, John M. Mariadason, Lisa M. Butler, Linden J. Gearing, Niall M. Corcoran, Stefano Mangiola, Katie L. Owen, Peter I. Croucher, Natasha K Brockwell, Daniel L. Roden, Alexander Swarbrick, Ruth J. Lyons, Weng Hua Khoo, Matthew K.H. Hong, Anupama Pasam, Chia Ling Chan, Andrew Ryan, Michelle M. McDonald, Vanessa M. Hayes, Hendrika M. Duivenvoorden, Tri Giang Phan, Damien Zanker, Paul J. Hertzog, Shahneen Sandhu, Christopher M. Hovens, Marek Cmero, Belinda S. Parker
Publikováno v:
EMBO Reports
The latency associated with bone metastasis emergence in castrate‐resistant prostate cancer is attributed to dormancy, a state in which cancer cells persist prior to overt lesion formation. Using single‐cell transcriptomics and ex vivo profiling,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d1e84dc3ba88b9fe110748c95dfd5f9
Autor:
Natasha K Brockwell, Belinda S. Parker, Gareth Rivalland, Thomas John, Beena Kumar, Muhammad Alamgeer
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Malignant pleural mesothelioma (MPM) is well known as an aggressive disease with poor survival. This has sparked trials of alternate immune-based therapies in MPM. While up to a quarter of MPM patients respond to immune checkpoint inhibit
Autor:
Robert W. Wilkinson, Hendrika M. Duivenvoorden, Damien Zanker, Alex J. Spurling, Stefanie R. Mullins, Belinda S. Parker, Tina Robinson, Natasha K Brockwell, Katie L. Owen, Paul J. Hertzog, Jasmine M. Zakhour
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 9, Pp n/a-n/a (2020)
Clinical & Translational Immunology
Clinical & Translational Immunology
Objectives Loss of tumor‐inherent type I interferon (IFN) signalling has been closely linked to accelerated metastatic progression via decreased immunogenicity and antitumor immunity. Previous studies in murine models of triple‐negative breast ca